Delivery Order SPE2DB22D1106-SPE2DB24FDNX7
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 10,000 units of chorionic gonad medication. The award, valued at $9,162.94, is a firm fixed-price delivery order contract with a completion date of February 15, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is also registered as a federal contractor. Cencora, Inc. holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $13,102.59 Firm Fixed Price Delivery Order is for the supply of 10,000 units of Chorionic Gonad, a pharmaceutical product. The contract has an ultimate completion date of May 3, 2024. Amerisourcebergen is a major pharmaceutical distributor that serves as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 10,000 units of chorionic gonad, a pharmaceutical product, to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order contract is valued at $3,783.72 and runs through July 2024. Amerisourcebergen is a major supplier of pharmaceutical and medical products to the U.S. federal government, with a focus on serving the Department of Defense (DoD) and Department of Veterans...
- This federal contract award, with ID SPE2DB22D3004|SPE2DB24FPD12, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,095.62 firm fixed-price delivery order is for the supply of 10,000 units of Chorionic Gonad, a pharmaceutical product. The contract has an ultimate completion date of January 31, 2024 and was awarded on January 30, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $7,332.15 firm fixed-price delivery order is for the supply of 10,000 units of Chorionic Gonad, a medical product. The award has an ultimate completion date of February 28, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The firm fixed price delivery order, valued at $8,122.22, is for the supply of 10,000 units of chorionic gonad, a medical product. The contract has an ultimate completion date of March 22, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with...
- Amerisourcebergen Drug Corp, through its Corporate Office division, was awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide 10,000 units of Chorionic Gonad with a potential value of $8,113.20. The contract has a completion date of February 20, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. and is the prime contractor on this delivery order, which is issued under a larger indefinite...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00 through December 2025. The contract provides for the delivery of 4,556,181,518 units of Chorionic Gonad 10,000 Unit Vials, a pharmaceutical product, at a ceiling value of $6,306.20. This award has a completion date of February 8, 2022 and was...
- This federal contract award, SPE2DB20D3104|SPE2DB22FV7H2, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $2,962.51, is for the delivery of 4,557,462,420 units of Chorionic Gonad 10,000 unit vials. The contract is a Firm Fixed Price Delivery Order with a completion date of June 8, 2022. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a critical supplier to various government...
- The Defense Logistics Agency issued a $2,086.28 delivery order to Amerisourcebergen Drug Corp on May 14, 2026, for 10,000 units of chorionic gonad (VLS), with an ultimate completion date of May 15, 2026. Place of performance is Conshohocken, PA. The order is firm fixed price with no set-aside. Amerisourcebergen Drug Corp is a pharmaceutical distributor and medical supplier subsidiary of Cencora, Inc., holding a single-award indefinite delivery contract with the Defense Logistics Agency valued at...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FDNX7Delivery Order
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,880.53, is for the delivery of 10,000 units of Chorionic Gonad, a medical product. The contract has a completion date of December 4, 2023 and is a firm fixed-price contract. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit organization that specializes in the distribution of pharmaceutical products and medical supplies to federal government agencies, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for delivering a comprehensive range of medical commodities to DoD facilities worldwide. This delivery order is likely fulfilled under the terms of that larger IDC contract. The contract award does not indicate any set-aside designation, suggesting it was awarded through full and open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 12/1/23 |